Parnax Lab

Parnax Lab

141.30
+2.95
(2.13%)
Market Cap
158.90 Cr
EPS
10.05
PE Ratio
14.70
Dividend Yield
0.00 %
Industry
Healthcare
52 Week High
193.50
52 Week Low
81.00
PB Ratio
1.91
Debt to Equity
1.01
Add Ratio
hide

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%

Company News

View All News
Caret
positive
Parnax Lab Limited Reports Q1 FY2026 Results, Schedules 43rd AGM and Appoints New Secretarial AuditorAug 13, 2025
Parnax Lab Limited approved its unaudited standalone and consolidated financial results for the quarter ended June 30, 2025. On a standalone basis, the company reported revenue from operations of Rs. 196.75 lakhs and net profit of Rs. 23.49 lakhs with basic EPS of Rs. 0.20. On a consolidated basis, revenue from operations reached Rs. 5,337.55 lakhs with net profit of Rs. 327.49 lakhs and basic EPS of Rs. 2.85. The company scheduled its 43rd Annual General Meeting for September 29, 2025, to be conducted via video conferencing. Additionally, the board approved the appointment of M/s HSPN & Associates LLP as Secretarial Auditor for a five-year term from FY 2025-2026 to FY 2029-2030, subject to shareholder approval at the upcoming AGM.
negative
Parnax Lab: Q3 Profit Plunges 44.5% Amid Revenue DeclineFeb 12, 2025
Parnax Lab reported Q3 FY25 results with revenue down 21.12% YoY to ₹40.22 crore and profit falling 44.5% to ₹1.21 crore. Operating income decreased by 53.11% QoQ and 40.57% YoY. EPS dropped to ₹1.06, a 44.21% YoY decline.
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,620.20
#1 3,86,412.90
33.69
#1 54,729.00
9.71
#1 10,980
-19.84
49.41
6,051.50
1,61,922.60
70.16
9,712.00
18.67
2,191
26.74
46.47
1,559.60
1,25,921.60
23.34
28,409.50
7.12
5,291
9.88
51.03
3,548.30
1,19,657.40
59.22
11,539.40
6.99
1,911
19.91
42.91
1,311.40
1,09,362.20
#1 19.25
33,741.20
16.73
5,725
1.26
60.11
2,570.20
1,06,063.00
56.09
12,744.20
#1 20.90
2,007
-18.14
53.12
1,033.80
1,04,094.90
22.34
23,511.00
18.55
4,615
2.60
62.88
2,031.20
93,704.80
25.33
22,909.50
13.74
3,306
#1 51.64
68.18
5,472.50
65,796.60
28.96
13,458.30
3.70
2,216
21.39
70.33
30,970.00
65,724.10
45.31
6,684.70
9.64
1,414
11.55
39.16
Forecast
Actual
Growth Rate
Revenue Growth
12.53 %
Net Income Growth
11.63 %
Cash Flow Change
-24.06 %
ROE
-3.24 %
ROCE
-22.56 %
EBITDA Margin (Avg.)
-8.93 %

Quarterly Financial Results

Quarterly Financials
Mar 2015
Jun 2015
Sept 2015
Dec 2015
Mar 2016
Jun 2016
Sept 2016
Dec 2016
Mar 2017
Jun 2017
Sept 2017
Dec 2017
Mar 2018
Jun 2018
Sept 2018
Dec 2018
Mar 2019
Jun 2019
Sept 2019
Dec 2019
Mar 2020
Jun 2020
Sept 2020
Dec 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Revenue
26
16
19
17
19
22
25
27
22
23
36
25
23
23
43
24
21
21
26
26
24
18
27
25
21
29
36
51
48
37
43
47
41
49
43
51
47
50
49
40
50
54
Expenses
23
14
16
15
17
18
22
23
19
21
31
22
21
21
37
21
19
19
23
24
23
15
22
22
21
25
30
44
41
31
38
40
36
42
37
45
41
42
41
36
42
46
EBITDA
3
3
3
3
2
3
3
4
2
2
5
3
1
3
6
2
1
2
3
1
1
3
5
3
-0
3
6
7
7
5
6
7
5
7
6
6
6
9
8
5
7
8
Operating Profit %
10 %
17 %
17 %
14 %
8 %
15 %
13 %
14 %
10 %
9 %
13 %
11 %
2 %
11 %
12 %
8 %
4 %
10 %
11 %
5 %
2 %
15 %
18 %
11 %
-2 %
12 %
16 %
14 %
15 %
14 %
13 %
16 %
12 %
13 %
12 %
12 %
13 %
17 %
15 %
11 %
14 %
14 %
Depreciation
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
2
2
2
2
2
2
2
2
2
2
2
2
2
2
Interest
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
2
1
1
1
1
Profit Before Tax
1
1
2
1
0
2
1
2
0
0
3
1
-1
1
4
0
-1
0
0
-1
-2
0
2
0
-3
1
3
5
4
3
3
4
2
4
2
3
3
5
5
2
4
5
Tax
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
0
0
0
0
0
0
0
4
1
1
1
1
1
1
1
1
1
2
0
1
1
Net Profit
1
1
1
1
0
2
1
2
0
0
3
1
-1
1
4
0
-1
0
0
-1
-3
0
2
0
-3
1
3
5
-0
2
2
3
1
3
2
2
2
4
3
1
3
3
EPS in ₹
1.29
1.00
1.65
0.99
0.31
1.88
1.27
1.91
0.35
0.18
3.43
0.75
-0.82
0.85
4.89
0.46
-0.82
0.09
0.42
-0.97
-3.02
0.27
2.82
0.14
-3.65
1.15
3.38
5.37
-0.18
1.97
1.83
2.96
1.30
2.90
1.63
1.90
1.95
3.47
2.97
1.06
2.55
2.85

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Total Assets
83
79
86
87
95
107
106
154
145
189
190
Fixed Assets
36
38
47
44
51
58
60
72
77
90
118
Current Assets
38
31
31
37
37
46
39
71
57
72
65
Capital Work in Progress
1
2
0
0
0
3
5
3
2
21
1
Investments
0
0
0
0
0
0
0
0
0
0
26
Other Assets
46
39
38
43
43
46
42
78
66
79
4
Total Liabilities
83
79
86
87
95
107
106
154
145
189
190
Current Liabilities
31
29
36
37
36
53
54
81
63
82
74
Non Current Liabilities
27
23
18
18
23
22
19
24
20
35
32
Total Equity
25
28
31
33
36
33
33
48
62
72
83
Reserve & Surplus
17
19
23
24
27
24
24
37
51
60
72
Share Capital
9
9
9
9
9
9
9
10
12
12
12

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Net Cash Flow
2
-2
0
1
-1
0
-0
4
-3
-1
Investing Activities
-4
-6
-10
-5
-11
-13
-7
-17
-10
-32
Operating Activities
-0
4
16
13
9
9
6
9
21
16
Financing Activities
6
1
-5
-7
1
5
0
12
-14
15

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Apr 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Promoter
62.59 %
62.59 %
62.59 %
62.59 %
67.58 %
67.58 %
67.58 %
72.30 %
72.30 %
72.30 %
72.30 %
72.30 %
72.30 %
72.30 %
72.30 %
72.30 %
72.30 %
72.30 %
72.30 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
DIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
33.46 %
33.99 %
33.31 %
33.30 %
29.07 %
29.07 %
28.30 %
23.90 %
23.83 %
24.59 %
24.86 %
24.88 %
24.46 %
24.45 %
24.60 %
24.26 %
24.68 %
24.73 %
24.97 %
Others
3.95 %
3.42 %
4.10 %
4.11 %
3.35 %
3.35 %
4.12 %
3.80 %
3.88 %
3.11 %
2.84 %
2.83 %
3.25 %
3.26 %
3.11 %
3.44 %
3.02 %
2.97 %
2.74 %
No of Share Holders
2,105
2,207
2,139
2,259
2,403
2,403
2,605
3,096
3,070
3,060
3,221
3,543
3,536
4,496
4,406
4,173
4,521
4,440
4,317

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
29 Sept 2025 ANNUAL GENERAL MEETING Annual General Meeting
NA
29 Sept 2025 122.45 138.35
27 Sept 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
27 Sept 2024 120.05 121.25
14 Nov 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
14 Nov 2024 150.00 150.50
10 Feb 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
10 Feb 2025 143.60 146.55
27 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
27 May 2025 96.78 92.48
13 Aug 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
13 Aug 2025 125.55 122.45

Announcements

Announcement under Regulation 30 (LODR)-Newspaper PublicationSep 06, 2025
Reg. 34 (1) Annual Report.Sep 06, 2025
Notice Of 43Rd Annual General Meeting Schedule To Be Held On Monday 29Th September 2025.Sep 06, 2025
Corporate Action- Fixes Book Closure For Annual General Meeting.Aug 29, 2025
Intimation Of Appointment Of Secretarial Auditor Under Regulation 24(A) And Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 (As Amended).Aug 13, 2025
Financial Results For The Quarter Ended June 30 2025.Aug 13, 2025
Board Meeting Outcome for Outcome Of Board Meeting For Approval Of Standalone And Consolidated Unaudited Results For The Quarter Ended June 30 2025.Aug 13, 2025
Board Meeting Intimation for For The Quarter Ended June 30 2025Aug 05, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 07, 2025
Closure of Trading WindowJun 27, 2025
Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 30, 2025
Financial Results For The Quarter And Year Ended March 31 2025.May 27, 2025
Board Meeting Outcome for Audited Financials Results For The Quarter And Year Ended March 31 2025.May 27, 2025
Board Meeting Intimation for Approval Of Audited Standalone And Consolidated IND- AS Compliant Financial Results For The Quarter (Q4) And Year Ended 31St March 2025.May 20, 2025
Announcement Under Regulation 30 W.R.T. Intimation Of Change In Email And Website Address Of Registrar And Transfer Agent (RTA) Of Parnax Lab Limited (Company).Apr 21, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 09, 2025
Announcement under Regulation 30 (LODR)-RetirementMar 31, 2025
Closure of Trading WindowMar 24, 2025
Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportMar 21, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementMar 21, 2025
Shareholder Meeting / Postal Ballot-Outcome of Postal_BallotMar 21, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 18, 2025
Shareholder Meeting / Postal Ballot-Notice of Postal BallotFeb 18, 2025
Integrated Filing (Financial)Feb 10, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementFeb 10, 2025
Unaudited Financial Results For The Quarter And Nine Months Ended December 31 2024.Feb 10, 2025
Board Meeting Outcome for Board Meeting Outcome For The BM Dated 10.02.2025Feb 10, 2025
Board Meeting Intimation for Consideration And Approval Of Standalone And Consolidated Un-Audited IND- AS Compliant Financial Results Along With Limited Review Report For The Quarter (Q3) And Nine MonJan 31, 2025
Announcement Under Regulation 30 W.R.T. Intimation Of Change In Name Of Registrar And Transfer Agent (RTA) Of Parnax Lab Limited (Company).Jan 28, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 09, 2025
Closure of Trading WindowDec 31, 2024
Announcement under Regulation 30 (LODR)-Change in ManagementNov 14, 2024
Unaudited Financial Results For The Quarter And Half Year Ended September 30, 2024Nov 14, 2024
Board Meeting Outcome for Unaudited Financial Results For The Quarter And Half Year Ended September 30, 2024Nov 14, 2024
Board Meeting Intimation for Consideration And Approval Of Unaudited Standalone And Consolidated Financial Results Along With Limited Review Report For The Quarter (Q2) And Half Year Ended 30Th September, 2024.Nov 06, 2024
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018Oct 14, 2024
Closure of Trading WindowSep 30, 2024
Shareholder Meeting / Postal Ballot-Scrutinizer''s ReportSep 27, 2024
Shareholder Meeting / Postal Ballot-Outcome of AGMSep 27, 2024
Announcement under Regulation 30 (LODR)-Newspaper PublicationSep 05, 2024
Reg. 34 (1) Annual Report.Sep 05, 2024
Notice Of 42Nd Annual General Meeting Schedule To Be Held On Friday, 27Th September, 2024.Sep 05, 2024
Corporate Action- Fixes Book Closure For Annual General MeetingSep 05, 2024
Announcement under Regulation 30 (LODR)-Newspaper PublicationSep 02, 2024
Financial Results For The Quarter And Three Months Ended June, 2024Aug 14, 2024
Board Meeting Outcome for Board Meeting OutcomeAug 14, 2024
Board Meeting Intimation for 1. Consideration And Approval Of Standalone And Consolidated Un-Audited IND- AS Compliant Financial Results Along With Limited Review Report For The Quarter (Q1) And Three Months Ended 30Th June, 2024.Aug 05, 2024
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018Jul 11, 2024
Announcement under Regulation 30 (LODR)-Resignation of DirectorJul 05, 2024
Announcement under Regulation 30 (LODR)-Change in ManagementJul 05, 2024

Technical Indicators

RSI(14)
Neutral
61.03
ATR(14)
Less Volatile
6.80
STOCH(9,6)
Neutral
69.20
STOCH RSI(14)
Neutral
36.66
MACD(12,26)
Bullish
0.12
ADX(14)
Strong Trend
34.45
UO(9)
Bearish
49.34
ROC(12)
Uptrend And Accelerating
9.19
WillR(14)
Neutral
-28.91